Ethyl 2-[2-(4-nitrophenyl)-1,3-thiazol-4-yl]acetate, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopentylpropanoic acid, 95.0%, 10g

Thiocyanate de sodium, min 98 %, pa, ACS, 500 g, emballage plastique.

DL-beta-3-m-Tolylalaninol, 97.0%, 5g

(S)-Methyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate, 96%, 1g

2-Bromophenyl Isothiocyanate>97.0%(GC)5g

Ethyl 3-amino-1-phenyl-1H-pyrazole-4-carboxylate, 95.0%, 100mg

ethyl 4-oxo-4-(4-n-propoxyphenyl)butyrate, 97.0%, 1g

Ethyl 4-(aminomethyl)benzoate, 97%, 1g

tert-Butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane, 95%, 1g

Ethyl 3-oxo-2-(p-tolyloxy)butyrate, 95.0%, 5g

CYCLOBUTANAMINE, 3-(2-FLUORO-4-METHOXYPHENOXY)-, HCL (1:1),TRANS-, 95.0%, 500mg

Solution Neissers III, 100 ml